Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
Tickers DNTH
Energous Announces Closing of Registered Direct Offering and Concurrent Warrant Exercise for $5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
From Energous
Via GlobeNewswire
Tickers WATT
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
IBEX Reports Strongest Quarterly Growth Rate in Nearly 3 Years, Record Fiscal Year 2025 Financial Results, Introduces Fiscal Year 2026 Guidance
From Ibex Limited
Via GlobeNewswire
Tickers IBEX
Trailblazer Acquisition Corp. Completes Upsized $275,000,000 Initial Public Offering
From Trailblazer Acquisition Corp.
Via GlobeNewswire
Robinhood Markets, Inc. Reports August 2025 Operating Data
From Robinhood Markets, Inc.
Via GlobeNewswire
Tickers HOOD
Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2026 Financial Results
From Frequency Electronics, Inc.
Via GlobeNewswire
Tickers FEIM
Monolithic Power Systems Announces Third Quarter 2025 Dividend
From Monolithic Power Systems, Inc.
Via GlobeNewswire
Tickers MPWR
Rent the Runway, Inc. Announces Second Quarter 2025 Results
From Rent The Runway, Inc.
Via GlobeNewswire
Tickers RENT
Precision Drilling Announces Renewal of Normal Course Issuer Bid
From Precision Drilling Corporation
Via GlobeNewswire
Tickers PDS TSX:PD
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
From Zealand Pharma
Via GlobeNewswire
Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum
From Recludix Pharma, Inc.
Via GlobeNewswire
Next Technology Holding Inc. Announces Reverse Stock Split
From Next Technology Holding Inc.
Via GlobeNewswire
Tickers NXTT
ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers NVO
USCIS Approves I-526E Petition for Investor in CMB Regional Centers Southern California Project
From CMB Regional Centers
Via GlobeNewswire
Allied Universal Honors 9/11
From Allied Universal Corp
Via GlobeNewswire
Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference
From Pennant Group, Inc.
Via GlobeNewswire
Tickers PNTG
Global Pioneer: KFSHRC Showcases Robotic Organ Transplantation Leadership at C3 Davos of Healthcare™ New York Summit
From King Faisal Specialist Hospital & Research Centre
Via GlobeNewswire
Morgan & Morgan Representing Customers Impacted by Hertz Data Breach
From Morgan & Morgan, P.A.
Via GlobeNewswire
From Basement Beginnings to 300 Stores
From Rally House
Via GlobeNewswire
Dayforce Named a Leader in the 2025 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises for Sixth Consecutive Year
From Dayforce, Inc.
Via GlobeNewswire
Tickers DAY TSX:DAY
Trinity Investors Announces Debut of F1® Arcade in Denver’s RiNo District
From Trinity Investors
Via GlobeNewswire
Aligned Data Centers Donates $100,000 to mikeroweWORKS Foundation, Championing Skilled Trades and Future Workforce Development
From Aligned Data Centers
Via GlobeNewswire
Transaction in Own Shares
From Shell plc
Via GlobeNewswire
Tickers SHEL
Ryze Superfoods Voluntarily Discontinues Health Claims for RYZE Mushroom Coffee and Matcha Following National Advertising Division Inquiry
From BBB NATIONAL PROGRAMS
Via GlobeNewswire
iPhone 17 Protection, Built for You, From Urban Armor Gear
From Urban Armor Gear
Via GlobeNewswire
PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS
From VALLOUREC
Via GlobeNewswire
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
From OSE Immunotherapeutics
Via GlobeNewswire
SUCCESS® Enterprises Launches Its Revamped Coaching Program
From SUCCESS ENTERPRISES LLC
Via GlobeNewswire
HII Increases Throughput, Expands Industrial Base through Distributed Shipbuilding
From HII
Via GlobeNewswire
Tickers HII
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.